Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-18

FDA Approved: DIVALPROEX SODIUM — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' divalproex sodium as a generic product under Original Application (ANDA 209286).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DIVALPROEX SODIUM (divalproex sodium)

Snippet

ORIG AP for DIVALPROEX SODIUM (DIVALPROEX SODIUM)